ABOUT THIS EPISODE
Dr. Emma Mead is the Chief Scientific Officer at the Oxford Drug Discovery Institute. In this episode, we explore with her the cutting-edge science behind Alzheimer’s and other neurodegenerative diseases.
Dr. Mead takes us through the journey from groundbreaking genetic discoveries to the development of potential therapies, explaining how tiny brain cells called microglia could hold the key to preventing and slowing dementia.
We dive into the complexities of Alzheimer’s beyond amyloid plaques, the promise of targeting genes like PLCG2, and the innovative approaches to drug discovery—from identifying molecular “hits” in the lab to partnering with pharmaceutical companies for clinical trials. Emma also shares her vision for a future where patients benefit from a toolbox of personalised treatments, early diagnosis, and improved quality of life.
This episode offers hope, insight, and a human perspective on a disease that affects one in two of us, directly or indirectly. Whether you’re a researcher, carer, or someone interested in the future of neuroscience, this conversation highlights why the next decade could transform dementia care.
If you have any questions for Justine and Prof Julie. Email us hello@twomindspodcast.co.uk.
For further help and advice please visit
https://www.alzheimers.org.uk.
Dr. Mead takes us through the journey from groundbreaking genetic discoveries to the development of potential therapies, explaining how tiny brain cells called microglia could hold the key to preventing and slowing dementia.
We dive into the complexities of Alzheimer’s beyond amyloid plaques, the promise of targeting genes like PLCG2, and the innovative approaches to drug discovery—from identifying molecular “hits” in the lab to partnering with pharmaceutical companies for clinical trials. Emma also shares her vision for a future where patients benefit from a toolbox of personalised treatments, early diagnosis, and improved quality of life.
This episode offers hope, insight, and a human perspective on a disease that affects one in two of us, directly or indirectly. Whether you’re a researcher, carer, or someone interested in the future of neuroscience, this conversation highlights why the next decade could transform dementia care.
If you have any questions for Justine and Prof Julie. Email us hello@twomindspodcast.co.uk.
For further help and advice please visit
https://www.alzheimers.org.uk.
English
United States
TRANSCRIPT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
OTHER EPISODES IN THIS PODCAST
In season one, we heard the story of Gareth and his battle with early-onset dementia as told by his wife Carrie. In this episode, we hear the story from a different perspective - this time from his daughter, Katie. Katie was in Year 8 in school when she learned about her dad’s condition. In the yea…
In this powerful and hopeful episode of In Two Minds, Professor Caleb Webber explains how vast new datasets and AI-driven pattern-spotting are transforming our understanding of conditions like Parkinson’s and Alzheimer’s.Caleb is the Director of Informatics at the UK Dementia Research Institute and…
Lucy Briers is part of acting royalty. Her dad Richard was in The Good Life. Her mum Ann Davies was in Doctor Who. Lucy herself is an accomplished actress and starred in the classic 1995 BBC adaptation of Pride and Prejudice. Over the next two episodes, Lucy talks to us about how she and her sister…
In this second part of our conversation with Lucy Briers, she talks candidly about the last few months of her Mum, Ann’s life and the coping strategies she used to help her.Lucy talks about how her mum looked ten years younger in her final days and seemed to remember her late husband, Richard, agai…
In a remarkable conversation, clinical neurologist and researcher Dr Tom Massey takes us inside the world of Huntington's Disease (HD) research, sharing the latest breakthroughs that have brought the scientific community closer than ever to a cure.Just weeks after this interview was recorded, news …
Disclaimer: The podcast and artwork embedded on this page are from Justine Pickering and Professor Julie Williams, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
EDIT
Thank you for helping to keep the podcast database up to date.
